Company Search:
Advanced Search
Sponsored Links
Prothena Corporation PLC Company Snapshot
Prothena Corporation PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Prothena Corporation PLC with three other companies in this sector in the United States: Geron Corporation (2018 sales of $1.07 million of which 100% was Diagnostic Products), Cue Biopharma Inc ($1.14 million ), and Avecho Biotechnology Ltd ($1.04 million ).

Sales Analysis. Sales fell dramatically in 2018: During the year ended December of 2018, sales at Prothena Corporation PLC were $955,000.00 . This is a sharp decrease of 96.5% versus 2017, when the company's sales were $27.52 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Prothena Corporation PLC
  Stock Performance Chart for Prothena Corporation PLC
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 7.76
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks -7.8%  
4 Weeks -19.8%   52 Weeks -37.9%  
Prothena Corporation PLC Key Data:
  Ticker: PRTA Country: Ireland
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 955,000
(Year Ending Jan 2019).
Employees: 59
  Currency: U.S. Dollars Market Cap: 309,597,313
  Fiscal Yr Ends: December Shares Outstanding: 39,896,561
  Share Type: Common Closely Held Shares: 13,663
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.